SOURCE: Elsevier Business Intelligence

Elsevier Business Intelligence

March 30, 2012 11:23 ET

Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360° London', April 25-26, 2012

LONDON--(Marketwire - Mar 30, 2012) -

Opening panel session to feature corporate buy-side's perspectives and include:

  • Arnaud Bernaert, SVP, Corporate Mergers and Acquisitions, Philips Healthcare
  • Stan Rabinovich, VP, Advanced Technology, Edwards LifeSciences
  • Townsend Goddard, Director, Business Development & Strategic Planning, Stryker
  • Edward Andrle, VP, Business Development & Strategy, Sorin Group
  • Bulend Corbacioglu, VP, Business Development and Licensing, Covidien

Elsevier Business Intelligence, the medtech industry's leading provider of strategic partnership and investment conferences, will host the 'IN3 Medical Device 360° London' investor conference on April 25-26, 2012, at the Millennium Gloucester Hotel & Conference Centre, London Kensington.

Building on the success of past IN3 events in Paris, Rome and Brussels, the 'IN3 Medical Device 360° London' conference will feature presentations by approximately 25 early-, mid- and late-stage start-up companies from around the world seeking funding and/or strategic partnership across the spectrum of diagnostic and therapeutic device markets. The conference also will feature an outstanding agenda of panels and networking sessions with industry thought leaders discussing pressing issues facing the global device industry in 2012 and beyond.

Additional participating speakers confirmed to date include: Aris Constantinides, Investment Director, NBGI Ventures; Victor Higgs, Managing Director, Applied Nanodetectors; Alan O'Connell, Partner, Seroba Kernel Life Sciences; Antoine Papiernik, Managing Partner, Sofinnova Partners; Thom Rasche, Partner, Earlybird Venture Capital; and Bleddyn Rees, Head of Healthcare, Wragge & Co. LLP, and Director, ECHAlliance.

Panel topics will include: Corporate Buy-Side Perspective: What Are Buyers Looking for in 2012?; Business Challenges Facing Wireless Health Ventures; and Raising Venture Capital in Europe: The Best of Times or the Worst of Times? In addition, the two-day program will feature profile presentations by the following healthcare investment firms, among others: Forbion, Gilde Healthcare Partners, Fountain Healthcare Partners, Wellington Partners, Delta Partners, Peppermint VIP, and Family Office Fund. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.

This two-day special event will benefit a wide variety of participants in the global medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in London should contact Kayleen Kell at 949-797-7142, or email k.kell@elsevier.com.

IN3 Medical Device 360° London will be held at the Millennium Gloucester Hotel & Conference Centre, London Kensington. Event co-sponsors to date include Ronald Trahan Associates Inc., Aptiv Solutions, Marketwire, Mass Medical Angels, Life Science Intelligence and Scisive Consulting LP. Visit www.IN3London.com for full conference and registration details. EBI will be hosting two additional IN3 Medical Device 360° events in 2012, in Boston and San Francisco; visit www.elsevierbi.com/conferences for more information.

Presenting companies to date include: Anethon, CellCoTec, Cortical Dynamics Ltd., Endomagnetics Ltd., Endomagnetics, Enox BioPharma, Implandata Ophthalmic Products GmbH, N8 Medical Inc., NUUBO, QSTREAM VASCULAR, Replication Medical Inc., Sapiens Steering Brain Stimulation, Soft Tissue Regeneration Inc., Specialty Scanners plc, Vantix Ltd., and Vascular Flow Technologies Ltd.

About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.

Contact Information

  • Contact:
    Ronald Trahan, APR
    Ronald Trahan Associates Inc.
    508-359-4005, x108